Correlation Between Aerovate Therapeutics and 718546AK0

Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and 718546AK0 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and 718546AK0 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aerovate Therapeutics and PHILLIPS 66 465, you can compare the effects of market volatilities on Aerovate Therapeutics and 718546AK0 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of 718546AK0. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and 718546AK0.

Diversification Opportunities for Aerovate Therapeutics and 718546AK0

0.18

Correlation Coefficient

Aerovate Therapeutics  718546AK0

Average diversification

The 3 months correlation between Aerovate and 718546AK0 is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and PHILLIPS 66 465 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PHILLIPS 66 465 and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with 718546AK0. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PHILLIPS 66 465 has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and 718546AK0 go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and 718546AK0

Given the investment horizon of 90 days Aerovate Therapeutics is expected to under-perform the 718546AK0. In addition to that, Aerovate Therapeutics is 2.88 times more volatile than PHILLIPS 66 465. It trades about -0.04 of its total potential returns per unit of risk. PHILLIPS 66 465 is currently generating about 0.06 per unit of volatility. If you would invest  9,619  in PHILLIPS 66 465 on December 5, 2024 and sell it today you would earn a total of  233.00  from holding PHILLIPS 66 465 or generate 2.42% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	98.33%
Values	Daily Returns

Aerovate Therapeutics  vs.  PHILLIPS 66 465

Aerovate Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Aerovate Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Aerovate Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

PHILLIPS 66 465

Risk-Adjusted Performance

Very Weak

Compared to the overall equity markets, risk-adjusted returns on investments in PHILLIPS 66 465 are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, 718546AK0 is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Aerovate Therapeutics and 718546AK0

The main advantage of trading using opposite Aerovate Therapeutics and 718546AK0 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, 718546AK0 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 718546AK0 will offset losses from the drop in 718546AK0's long position.

The idea behind Aerovate Therapeutics and PHILLIPS 66 465 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.